Meta-analyses to investigate gene-environment interactions in neuroepidemiology

Neuroepidemiology

Volumn 42, Issue 1, 2013, Pages 39-49

  Van Der Mei, I A F ^a   Otahal, P ^a   Simpson Jr , S ^a   Taylor, B ^a   Winzenberg, T ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Environment; Gene; Meta analysis; Neurological disease

Indexed keywords

ALLELE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; ETHNICITY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPOTHESIS; MEDICAL LITERATURE; META ANALYSIS (TOPIC); NEUROEPIDEMIOLOGY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHENOTYPE; PRACTICE GUIDELINE; PUBLISHING; RATING SCALE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STUDY DESIGN; SYSTEMATIC REVIEW (TOPIC); SYSTEMATIC REVIEW;

ANIMALS; EPIDEMIOLOGIC RESEARCH DESIGN; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PUBLICATION BIAS;

EID: 84898403357     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000355439     Document Type: Article

References (42)

1. Hunter DJ: Gene-environment interactions in human diseases. Nat Rev Genet 2005; 6: 287-298.
2. Lin R, Taylor BV, Simpson S, Jr., Charlesworth J, Ponsonby AL, Pittas F, Dwyer T, van der Mei IA: Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis. J Neurol Neurosurg Psychiatry 2013, in press.
3. Ottman R: Gene-environment interaction: definitions and study designs. Prev Med 1996; 25: 764-770.
4. Simon KC, van der Mei IA, Munger KL, Ponsonby A, Dickinson J, Dwyer T, Sundstrom P, Ascherio A: Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1 1501 on multiple sclerosis risk. Neurology 2010; 74: 1365-1371.
5. Rothman KJ: Synergy and antagonism in cause-effect relationships. Am J Epidemiol 1974; 99: 385-388.
6. Skrondal A: Interaction as departure from additivity in case-control studies: a cautionary note. Am J Epidemiol 2003; 158: 251-258.
7. Rothman K: Interaction between causes; in Rothman K (ed): Modern Epidemiology. Boston, Little, Brown and Company, 1986, pp 311-326.
8. Botto LD, Khoury MJ: Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol 2001; 153: 1016-1020.
9. Piegorsch WW, Weinberg CR, Taylor JA: Non-hierarchical logistic models and caseonly designs for assessing susceptibility in population-based case-control studies. Stat Med 1994; 13: 153-162.
10. Dennis J, Hawken S, Krewski D, Birkett N, Gheorghe M, Frei J, McKeown-Eyssen G, Little J: Bias in the case-only design applied to studies of gene-environment and gene-gene interaction: a systematic review and metaanalysis. Int J Epidemiol 2011; 40: 1329-1341.
11. Crabb DW, Matsumoto M, Chang D, You M: Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 2004; 63: 49-63.
12. Gatto NM, Campbell UB, Rundle AG, Ahsan H: Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias. Int J Epidemiol 2004; 33: 1014-1024.
13. Wacholder S, Rothman N, Caporaso N: Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Nat Cancer Inst 2000; 92: 1151-1158.
14. Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0. The Cochrane Collaboration, updated March 2011. www.cochrane-handbook. org.
15. Altman DG, Bland JM: Interaction revisited: the difference between two estimates. BMJ 2003; 326: 219.
16. Sutton AJ, Higgins JP: Recent developments in meta-analysis. Stat Med 2008; 27: 625-650.
17. Kim-Cohen J, Caspi A, Taylor A, Williams B, Newcombe R, Craig IW, Moffitt TE: MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry 2006; 11: 903-913.
18. Thompson SG, Higgins JP: How should metaregression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-1573.
19. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L: Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006; 295: 676-680.
20. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J: The quality of meta-analyses of genetic association studies: a review with recommendations. Am J Epidemiol 2009; 170: 1333-1343.
21. Little J, Higgins JPT (eds): The HuGENet HuGE Review Handbook, version 1.0. 2006. http://www.hugenet.ca.
22. Palla L, Higgins JP, Wareham NJ, Sharp SJ: Challenges in the use of literature-based meta- analysis to examine gene-environment interactions. Am J Epidemiol 2010; 171: 1225- 1232.
23. Keijzer MB, Borm GF, Blom HJ, Bos GM, Rosendaal FR, den Heijer M: No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis: results of a meta-analysis of published studies and a large case-only study. Thromb Haemost 2007; 97: 32-37.
24. Zeiger JS, Beaty TH, Liang KY: Oral clefts, maternal smoking, and TGFA: a meta-analysis of gene-environment interaction. Cleft Palate Craniofac J 2005; 42: 58-63.
25. Kocarnik JD, Hutter CM, Slattery ML, Berndt SI, Hsu L, Duggan DJ, Muehling J, Caan BJ, Beresford SA, Rajkovic A, Sarto GE, Marshall JR, Hammad N, Wallace RB, Makar KW, Prentice RL, Potter JD, Hayes RB, Peters U: Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010; 19: 3131-3139.
26. Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch RA, Brockmoller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, Okkels H, Romkes M, Roots I, Rothman N: Cigarette smoking, Nacetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 2000; 9: 461-467.
27. Hartz SM, Short SE, Saccone NL, et al: Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. Arch Gen Psychiatry 2012; 69: 854-860.
28. Nettleton JA, Hivert MF, Lemaitre RN, et al: Meta-analysis investigating associations between healthy diet and fasting glucose and insulin levels and modification by loci associated with glucose homeostasis in data from 15 cohorts. Am J Epidemiol 2013; 177: 103-115.
29. Stang A: Critical evaluation of the Newcastle- Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605.
30. Morimoto LM, White E, Newcomb PA: Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol 2003; 158: 259-263.
31. Wacholder S, Chatterjee N, Hartge P: Joint effect of genes and environment distorted by selection biases: implications for hospitalbased case-control studies. Cancer Epidemiol Biomarkers Prev 2002; 11: 885-889.
32. Clayton D, McKeigue PM: Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001; 358: 1356-1360.
33. Garcia-Closas M, Lubin JH: Power and sample size calculations in case-control studies of gene-environment interactions: comments on different approaches. Am J Epidemiol 1999; 149: 689-692.
34. Ioannidis JP, Ntzani EE, Trikalinos TA: 'Racial' differences in genetic effects for complex diseases. Nat Genet 2004; 36: 1312-1318.
35. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MT, Petryshen TL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D: Assessing the impact of population stratification on genetic association studies. Nat Genet 2004; 36: 388-393.
36. Knol MJ, Egger M, Scott P, Geerlings MI, Vandenbroucke JP: When one depends on the other: reporting of interaction in casecontrol and cohort studies. Epidemiology 2009; 20: 161-166.
37. Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007; 4:e297.
38. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J, Scheet P, Gwinn M, Williamson RE, Zou GY, Hutchings K, Johnson CY, Tait V, Wiens M, Golding J, van Duijn C, McLaughlin J, Paterson A, Wells G, Fortier I, Freedman M, Zecevic M, King R, Infante-Rivard C, Stewart A, Birkett N: Strengthening the reporting of genetic association studies (STREGA): an extension of the strobe statement. Hum Genet 2009; 125: 131- 151.
39. Caspi A, McClay J, Moffitt TE, et al: Role of genotype in the cycle of violence in maltreated children. Science 2002; 297: 851-854.
40. Foley DL, Eaves LJ, Wormley B, et al: Childhood adversity, monoamine oxidase A genotype, and risk for conduct disorder. Arch Gen Psychiatry 2004; 61: 738-744.
41. Haberstick BC, Lessem JM, Hopfer CJ, et al: Monoamine oxidase A (MAOA) and antisocial behaviors in the presence of childhood and adolescent maltreatment. Am J Med Ge net B Neuropsychiatr Genet 2005; 135B: 59-64.
42. Nilsson KW, Sjoberg RL, Damberg M, et al: Role of monoamine oxidase A genotype and psychosocial factors in male adolescent criminal activity. Biol Psychiatry 2006; 59: 121- 127.